"Visitation restrictions are currently in place to decrease possible exposure to Coronavirus (COVID-19). Please visit our website for more information. CHI Health Midlands is dedicated to delivering high quality, compassionate care to Papillion and nearby communities. Visit us at 11111 S 84th St or call (402) 593-3000 for more information."

During the past decade, Midlands Community Hospital conducted 128 clinical trials. In the 10-year time frame, 128 clinical trials started and 50 clinical trials were completed, i.e. on average, 39.1% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 43 clinical trials were completed. i.e. 82.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Midlands Community Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 80 trials, followed by "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "SWOG Cancer Research Network" with 31 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "Eastern Cooperative Oncology Group" with 16 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Midlands Community Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 101 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Eastern Cooperative Oncology Group" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Midlands Community Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Breast Cancer" (7 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Midlands Community Hospital" in a lesser frequency.

Most popular intervention types in "Midlands Community Hospital" are "Drug" (144 trials), "Other" (100 trials), "Biological" (78 trials), "Procedure" (48 trials) and "Radiation" (22 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (50 trials), "Quality-of-Life Assessment" (38 trials), "Computed Tomography" (25 trials), "Nivolumab" (25 trials) and "Questionnaire Administration" (24 trials). Other intervention names were less common.

The vast majority of trials in "Midlands Community Hospital" are 145 trials for "All" genders, 30 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Midlands Community Hospital". undefined are not yet recruiting, 53 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Midlands Community Hospital, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Midlands Community Hospital, 4 "Phase 1" clinical trials were conducted, 84 "Phase 2" clinical trials and 94 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".